The team behind USD1, the fast-growing stablecoin launched by Trump family-linked DeFi project World Liberty Financial, has fallen behind on updating its monthly attestation reports, a critical transparency measure for investors and regulators, according to NYDIG.As of early October, the most recent report available is from July. That delay puts USD1 out of step with rivals like Circle’s USDC, which published reserve data through August, and Tether, which reports quarterly, Greg Cipolaro, Global Head of Research at NYDIG, said in a report.“For a project of USD1’s stature, up-to-date attestations are non-negotiable,” Cipolaro wrote.CoinDesk has reached out to BitGo and World Liberty Financial for comment but hasn’t heard back by the time of writing.The BitGo connectionWhile BitGo Trust oversees custody of the stablecoin’s reserves, the issuer, BitGo Technologies, hasn’t explained the gap in reporting. The lapse is notable given USD1’s rising profile and $2.7 billion in supply, he noted.At the same time, USD1’s token distribution suggests most of its traction is offshore. NYDIG claims that its analysis of top wallets shows that roughly 78% of the supply sits in addresses linked to overseas exchanges.Looking ahead, USD1’s structure may conflict with the incoming GENIUS Act. The law, expected to take effect by early 2027, limits stablecoin issuance to subsidiaries of regulated banks or state-qualified entities.NYDIG also said that BitGo Technologies doesn’t currently appear fit either in the regulated banks or state-qualified entities category, meaning structural changes may be required, Cipolaro wrote.The team behind USD1, the fast-growing stablecoin launched by Trump family-linked DeFi project World Liberty Financial, has fallen behind on updating its monthly attestation reports, a critical transparency measure for investors and regulators, according to NYDIG.As of early October, the most recent report available is from July. That delay puts USD1 out of step with rivals like Circle’s USDC, which published reserve data through August, and Tether, which reports quarterly, Greg Cipolaro, Global Head of Research at NYDIG, said in a report.“For a project of USD1’s stature, up-to-date attestations are non-negotiable,” Cipolaro wrote.CoinDesk has reached out to BitGo and World Liberty Financial for comment but hasn’t heard back by the time of writing.The BitGo connectionWhile BitGo Trust oversees custody of the stablecoin’s reserves, the issuer, BitGo Technologies, hasn’t explained the gap in reporting. The lapse is notable given USD1’s rising profile and $2.7 billion in supply, he noted.At the same time, USD1’s token distribution suggests most of its traction is offshore. NYDIG claims that its analysis of top wallets shows that roughly 78% of the supply sits in addresses linked to overseas exchanges.Looking ahead, USD1’s structure may conflict with the incoming GENIUS Act. The law, expected to take effect by early 2027, limits stablecoin issuance to subsidiaries of regulated banks or state-qualified entities.NYDIG also said that BitGo Technologies doesn’t currently appear fit either in the regulated banks or state-qualified entities category, meaning structural changes may be required, Cipolaro wrote.

Trump-Linked World Liberty Financial's Stablecoin Needs Better Attestation Reports, NYDIG Says

2025/10/05 22:00
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The team behind USD1, the fast-growing stablecoin launched by Trump family-linked DeFi project World Liberty Financial, has fallen behind on updating its monthly attestation reports, a critical transparency measure for investors and regulators, according to NYDIG.

As of early October, the most recent report available is from July. That delay puts USD1 out of step with rivals like Circle’s USDC, which published reserve data through August, and Tether, which reports quarterly, Greg Cipolaro, Global Head of Research at NYDIG, said in a report.

“For a project of USD1’s stature, up-to-date attestations are non-negotiable,” Cipolaro wrote.

CoinDesk has reached out to BitGo and World Liberty Financial for comment but hasn’t heard back by the time of writing.

The BitGo connection

While BitGo Trust oversees custody of the stablecoin’s reserves, the issuer, BitGo Technologies, hasn’t explained the gap in reporting. The lapse is notable given USD1’s rising profile and $2.7 billion in supply, he noted.

At the same time, USD1’s token distribution suggests most of its traction is offshore. NYDIG claims that its analysis of top wallets shows that roughly 78% of the supply sits in addresses linked to overseas exchanges.

Looking ahead, USD1’s structure may conflict with the incoming GENIUS Act. The law, expected to take effect by early 2027, limits stablecoin issuance to subsidiaries of regulated banks or state-qualified entities.

NYDIG also said that BitGo Technologies doesn’t currently appear fit either in the regulated banks or state-qualified entities category, meaning structural changes may be required, Cipolaro wrote.

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.085
$3.085$3.085
-1.43%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09